US FDA green lights first gene therapy for bladder cancer
The US Food and Drug Administration (FDA) has approved the first gene therapy for patients with a high-risk form of bladder cancer.
The US Food and Drug Administration (FDA) has approved the first gene therapy for patients with a high-risk form of bladder cancer.
Swedish company, Bio-Works, has awarded an EU grant to develop a more sustainable method of biotherapeutic purification.